TREM-1 amplifies trophoblastic inflammation via activating NF-κB pathway during preeclampsia

Placenta - Tập 115 - Trang 97-105 - 2021
Yin Xie1, Xuanxuan Li1, Dan Lv1, Mengzhou He1, Yanan Sun1, Xingguang Lin1, Yao Fan1, Meitao Yang2, Heze Xu1, Xiaolei Zhang1, Yanling Zhang1, Rajluxmee Beejadhursing1, Fanfan Li1, Dongrui Deng1
1Department of Gynecology and Obstetrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, China
2Department of Gynecology and Obstetrics, Zhongnan Hospital, Wuhan University, Wuhan, 430071, China

Tài liệu tham khảo

Rana, 2019, Preeclampsia: pathophysiology, challenges, and perspectives, Circ. Res., 124, 1094, 10.1161/CIRCRESAHA.118.313276 Chen, 2014, Pre-eclampsia and cardiovascular disease, Cardiovasc. Res., 101, 579, 10.1093/cvr/cvu018 Redman, 1991, Current topic: pre-eclampsia and the placenta, Placenta, 12, 301, 10.1016/0143-4004(91)90339-H Laresgoiti-Servitje, 2013, A leading role for the immune system in the pathophysiology of preeclampsia, J. Leukoc. Biol., 94, 247, 10.1189/jlb.1112603 Warning, 2011, A balancing act: mechanisms by which the fetus avoids rejection by the maternal immune system, Reproduction, 141, 715, 10.1530/REP-10-0360 Harmon, 2016, The role of inflammation in the pathology of preeclampsia, Clin. Sci., 130, 409, 10.1042/CS20150702 Hu, 2019, Protective effect of metformin on a rat model of lipopolysaccharide-induced preeclampsia, Fundam. Clin. Pharmacol., 33, 649, 10.1111/fcp.12501 Cotechini, 2014, Inflammation in rat pregnancy inhibits spiral artery remodeling leading to fetal growth restriction and features of preeclampsia, J. Exp. Med., 211, 165, 10.1084/jem.20130295 Kadam, 2019, Rosiglitazone blocks first trimester in-vitro placental injury caused by NF-kappaB-mediated inflammation, Sci. Rep., 9, 2018, 10.1038/s41598-018-38336-2 Bouchon, 2001, TREM-1 amplifies inflammation and is a crucial mediator of septic shock, Nature, 410, 1103, 10.1038/35074114 Roe, 2014, Triggering receptor expressed on myeloid cells-1 (TREM-1): a new player in antiviral immunity?, Front. Microbiol., 5, 627, 10.3389/fmicb.2014.00627 Ford, 2009, TREM and TREM-like receptors in inflammation and disease, Curr. Opin. Immunol., 21, 38, 10.1016/j.coi.2009.01.009 Genua, 2014, The triggering receptor expressed on myeloid cells (TREM) in inflammatory bowel disease pathogenesis, J. Transl. Med., 12, 293, 10.1186/s12967-014-0293-z Varkonyi, 2011, Microarray profiling reveals that placental transcriptomes of early-onset HELLP syndrome and preeclampsia are similar, Placenta, 32, S21, 10.1016/j.placenta.2010.04.014 Lim, 2014, TREM-1 expression is increased in human placentas from severe early-onset preeclamptic pregnancies where it may be involved in syncytialization, Reprod. Sci., 21, 562, 10.1177/1933719113503406 Molloy, 2009, Triggering receptor expressed on myeloid cells (TREM) family and the application of its antagonists, Recent Pat. Anti-Infect. Drug Discov., 4, 51, 10.2174/157489109787236292 Arts, 2013, TREM-1: intracellular signaling pathways and interaction with pattern recognition receptors, J. Leukoc. Biol., 93, 209, 10.1189/jlb.0312145 Hayden, 2012, NF-kappaB, the first quarter-century: remarkable progress and outstanding questions, Genes Dev., 26, 203, 10.1101/gad.183434.111 Vaughan, 2012, Activation of NF-kappaB in placentas of women with preeclampsia, Hypertens. Pregnancy, 31, 243, 10.3109/10641955.2011.642436 Feng, 2005, Establishment and characterization of a human first-trimester extravillous trophoblast cell line (TEV-1), J. Soc. Gynecol. Invest., 12, e21, 10.1016/j.jsgi.2005.02.008 Boufenzer, 2021, Potentiation of NETs release is novel characteristic of TREM-1 activation and the pharmacological inhibition of TREM-1 could prevent from the deleterious consequences of NETs release in sepsis, Cell. Mol. Immunol., 18, 452, 10.1038/s41423-020-00591-7 Wu, 2021, HBV upregulated triggering receptor expressed on myeloid cells-1 (TREM-1) expression on monocytes participated in disease progression through NF-Kb pathway, Clin. Immunol., 223, 108650, 10.1016/j.clim.2020.108650 Turhan, 2020, A promising novel biomarker for early-onset preeclampsia: soluble trigger receptor expressed on myeloid cells-1 (sTREM-1), J. Matern. Fetal Neonatal Med., 18, 1 Weiss, 2017, Reversal of TREM-1 ectodomain shedding and improved bacterial clearance by intranasal metalloproteinase inhibitors, Mucosal Immunol., 10, 1021, 10.1038/mi.2016.104 Bellos, 2018, The role of interleukins in preeclampsia: a comprehensive review, Am. J. Reprod. Immunol., 80, 10.1111/aji.13055 Redman, 1999, Preeclampsia: an excessive maternal inflammatory response to pregnancy, Am. J. Obstet. Gynecol., 180, 499, 10.1016/S0002-9378(99)70239-5 Eastabrook, 2011, The origins and end-organ consequence of pre-eclampsia, Best Pract. Res. Clin. Obstet. Gynaecol., 25, 435, 10.1016/j.bpobgyn.2011.01.005 Baruah, 2019, TREM-1 regulates neutrophil chemotaxis by promoting NOX-dependent superoxide production, J. Leukoc. Biol., 105, 1195, 10.1002/JLB.3VMA0918-375R Schmausser, 2008, Triggering receptor expressed on myeloid cells-1 (TREM-1) expression on gastric epithelium: implication for a role of TREM-1 in Helicobacter pylori infection, Clin. Exp. Immunol., 152, 88, 10.1111/j.1365-2249.2008.03608.x Tammaro, 2019, TREM1/3 deficiency impairs tissue repair after acute kidney injury and mitochondrial metabolic flexibility in tubular epithelial cells, Front. Immunol., 10, 1469, 10.3389/fimmu.2019.01469 Wang, 2017, Increased serum TREM-1 level is associated with in-stent restenosis, and activation of TREM-1 promotes inflammation, proliferation and migration in vascular smooth muscle cells, Atherosclerosis, 267, 10, 10.1016/j.atherosclerosis.2017.10.015 Holmlund, 2002, Expression and regulation of the pattern recognition receptors Toll-like receptor-2 and Toll-like receptor-4 in the human placenta, Immunology, 107, 145, 10.1046/j.1365-2567.2002.01491.x Park, 2020, SIRT1 alleviates LPS-induced IL-1beta production by suppressing NLRP3 inflammasome activation and ROS production in trophoblasts, Cells, 9, 10.3390/cells9030728 Kumar, 2010, NF-kappaB inhibitory action of resveratrol: a probable mechanism of neuroprotection in experimental diabetic neuropathy, Biochem. Biophys. Res. Commun., 394, 360, 10.1016/j.bbrc.2010.03.014 Gasparini, 2012, NF-kappaB as a target for modulating inflammatory responses, Curr. Pharmaceut. Des., 18, 5735, 10.2174/138161212803530763 Borgohain, 2017, Small molecule inhibiting nuclear factor-kB ameliorates oxidative stress and suppresses renal inflammation in early stage of alloxan-induced diabetic nephropathy in rat, Basic Clin. Pharmacol. Toxicol., 120, 442, 10.1111/bcpt.12718 Ho, 2008, TREM-1 expression in tumor-associated macrophages and clinical outcome in lung cancer, Am. J. Respir. Crit. Care Med., 177, 763, 10.1164/rccm.200704-641OC Sigalov, 2014, A novel ligand-independent peptide inhibitor of TREM-1 suppresses tumor growth in human lung cancer xenografts and prolongs survival of mice with lipopolysaccharide-induced septic shock, Int. Immunopharm., 21, 208, 10.1016/j.intimp.2014.05.001 Choi, 2011, Dietary fat increases solid tumor growth and metastasis of 4T1 murine mammary carcinoma cells and mortality in obesity-resistant BALB/c mice, Breast Cancer Res., 13, R78, 10.1186/bcr2927 Zhao, 2018, Vitamin D suppresses macrophage infiltration by down-regulation of TREM-1 in diabetic nephropathy rats, Mol. Cell. Endocrinol., 473, 44, 10.1016/j.mce.2018.01.001 Min, 2008, NF-kappaB and epithelial to mesenchymal transition of cancer, J. Cell. Biochem., 104, 733, 10.1002/jcb.21695